Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1975128
Reference Type
Journal Article
Title
Characterization of absorbable collagen sponges as rhBMP-2 carriers
Author(s)
Friess, W; Uludag, H; Foskett, S; Biron, R; Sargeant, C
Year
1999
Is Peer Reviewed?
Yes
Journal
International Journal of Pharmaceutics
ISSN:
0378-5173
EISSN:
1873-3476
Volume
187
Issue
1
Page Numbers
91-99
Language
English
PMID
10502616
DOI
10.1016/s0378-5173(99)00174-x
Web of Science Id
WOS:000083045300006
Abstract
For clinical use recombinant human bone morphogenetic protein (rhBMP-2) is soaked onto an absorbable collagen sponge (ACS) for bone regeneration. Therefore, loss of rhBMP-2 upon mechanical handling during implantation and a potential effect of the carrier on in vivo retention is of interest. The interactions between drug and carrier were looked at from the application mode and the amount of protein which can be mechanically expressed from the combination was investigated. The results indicated that rhBMP-2 binds to the collagen system. The most hydrophilic double extended homodimer showed the least binding affinity to ACS. By extending the waiting time between soaking and implantation, protein incorporation could be increased. In addition, the amount of rhBMP-2 which could be expressed was reduced by heavier ACS material and allowed for a shorter waiting period, especially at lower rhBMP-2 concentration. Crosslinking of ACS with formaldehyde led to reduced binding of rhBMP-2 to collagen either by direct hindrance of binding or reduction in swelling and number of binding sites available. Higher product pH or anion concentration enabled to increase rhBMP-2 incorporation but was limited by the potential precipitation of rhBMP-2. Despite a variety of chemical changes of ACS by ethylene oxide sterilization incorporation was not changed significantly. The in vivo release kinetics of 125I-rhBMP-2 from the collagen sponge were studied using a rat ectopic implant model. The ACS/rhBMP-2 systems tested demonstrated small, but significant differences in the in vivo retention of rhBMP-2. Consequently, it is important to have as little variability in pH, anion concentration, crosslinking and ACS mass as possible to achieve consistent or maximum binding and to avoid rhBMP-2 precipitation. Furthermore, these characteristics can be important for other in vivo applications.
Keywords
collagen; bone morphogenetic protein; sterilization; crosslinking
Tags
IRIS
•
Formaldehyde [archived]
Reproductive and Developmental Effects
Screened
Title/abstract
Methodology/therapeutics
Inflammation/Reactive Oxygen Species
WOS
PubMed
Screened by Title/Abstract
Related to Methodology or Process
Retroactive RIS import
2014
HERO_Formaldehyde_InflammationReactiveOxygenSpecies_pid_31_uid_5713Sorting091214
HERO_Formaldehyde_InflammationReactiveOxygenSpecies_pid_31_uid_5713
Screened (Title/Abstract)
Related to Methodology or Process
2015
FA DevRepro 072115
Methodology/Therapeutics-Population Criteria
•
IRIS Formaldehyde (Inhalation) [Final 2024]
Literature Indexing
PubMed
WoS
Literature Identification
Reproductive and Developmental Effects
Excluded
Inflammation and Immune-Related Mechanistic Studies
Excluded
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity